指南与共识男科与性医学

男性慢性盆腔疼痛:AUA指南第三部分——慢性阴囊内容物疼痛的治疗

Male Chronic Pelvic Pain: AUA Guideline: Part III Treatment of Chronic Scrotal Content Pain.
指南 / 共识 · J Urol · 2025-04-17

本指南为AUA三部分系列第三部分,聚焦慢性阴囊内容物疼痛(CSCP)的治疗。基于截至2023年6月的系统综述(2024年6月更新),专家组制定循证与共识声明,涵盖生活方式调整、药物及手术干预,但指出多数治疗为超说明书使用且证据不足。

要点

  • CSCP治疗需多学科协作并管理患者预期。
  • 可选生活方式调整、药物和手术干预。
  • 多数治疗缺乏充分数据,属超说明书使用。

核心结论

  • CSCP特异性数据缺乏,多数治疗为超说明书使用,需进一步研究。

研究设计与样本

  • 基于Ovid MEDLINE(1946年至2023年6月6日)、Cochrane对照试验中心注册库(至2023年5月)和Cochrane系统综述数据库(至2023年5月)的系统综述,2024年6月更新搜索。

主要发现

  • 专家组制定循证与共识声明指导CSCP治疗,包括生活方式调整、药物管理和手术干预。

临床怎么用

  • 治疗应多学科协作,通过支持性咨询管理预期,并讨论超说明书使用的性质。

局限性

  • CSCP特异性数据缺乏,多数治疗证据不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This Guideline covers the evaluation and treatment of men who present to a clinician with a complaint of chronic pelvic pain. This is Part III of a three-part series focusing on treatment of chronic scrotal content pain (CSCP). CSCP patients typically present with pain described in the testes with tenderness in the epididymis and/or spermatic cord. Patient education of the underlying etiology may promote discussion of treatment options, which often require a multidisciplinary approach that includes management of expectations through supportive counseling during treatment. For discussion of patient evaluation and treatment of chronic prostatitis/chronic pelvic pain syndrome, refer to Parts I and II of this series. MATERIALS AND METHODS: The systematic review that informs the Guideline statements was based on searches in Ovid MEDLINE (1946 to June 6, 2023), the Cochrane Central Register of Controlled Trials (through May 2023), and the Cochrane Database of Systematic Reviews (through May 2023). An updated search was conducted in June 2024. RESULTS: The Chronic Pelvic Pain Panel developed evidence- and consensus-based statements to provide guidance for treatment of patients with CSCP, which may include lifestyle modification, pharmacologic management, and procedural intervention. CONCLUSIONS: Specific data on CSCP are lacking with most management options described as off-label use. While there are multiple evolving treatments for CSCP that have shown promising results, most currently lack sufficient data to recommend as treatment and require further investigation to establish a role in patient care.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Lai HH, Pontari MA, Argoff CE, et al. Male Chronic Pelvic Pain: AUA Guideline: Part III Treatment of Chronic Scrotal Content Pain. J Urol. 2025. PMID: 40243106. doi:10.1097/JU.0000000000004566

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。